Literature DB >> 33291545

Comparative Study of Senescent Th Biomarkers in Healthy Donors and Early Arthritis Patients. Analysis of VPAC Receptors and Their Influence.

Raúl Villanueva-Romero1, Amalia Lamana1,2, Marissa Flores-Santamaría1, Mar Carrión1, Selene Pérez-García1, Ana Triguero-Martínez2, Eva Tomero2, Gabriel Criado3, José L Pablos3, Isidoro González-Álvaro2, Carmen Martínez1, Yasmina Juarranz1, Rosa P Gomariz1, Irene Gutiérrez-Cañas1.   

Abstract

Pro-inflammatory CD4+CD28- T cells are characteristic of immunosenescence, but also of several autoimmune/inflammatory diseases. Vasoactive intestinal peptide (VIP) acts as an anti-inflammatory and immunomodulatory mediator on these cells. Our objective was to study the mutual influence between senescent Th cells and VIP axis in early arthritis (EA), comparing with non-EA donors. We characterized the correlation between senescent Th cells and clinic parameters of EA as well as the behavior of senescent Th biomarkers by real-time PCR. Clinical data were systematically recorded at baseline and after 6 months of follow-up. The number of CD4+CD28- T cells measured by sorting is higher in patients who initially meet ACR classification criteria for rheumatoid arthritis (RA) compared to those who were classified as undifferentiated arthritis (UA). A slight positive correlation between EA CD4+CD28- T cells and CRP or ESR and a negative correlation with bone mineral density were found. Th senescent biomarkers in EA CD4+CD28- T cells were similar to donors, however some of them increased after 6 months of follow-up. VPAC receptors were analyzed by real-time PCR and immunofluorescence, and CD4+CD28- T cells showed higher expression of VPAC2 and lower of VPAC1, VPAC2 showing a significant increased expression in EA cells. Sorted CD4+CD28- T cells were in vitro expanded in presence of VIP, wherein VIP increased senescent biomarker CD27, while it diminished CD57 or NKG2 senescent biomarkers. Our study demonstrates for the first time the existence of a link between senescent Th cells and the VIP axis.

Entities:  

Keywords:  CD4+CD28− T cells; VIP; VPAC receptors; early arthritis; rheumatoid arthritis; senescent Th cells

Mesh:

Substances:

Year:  2020        PMID: 33291545      PMCID: PMC7761848          DOI: 10.3390/cells9122592

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  46 in total

1.  Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus.

Authors:  Hector F Valenzuela; Rita B Effros
Journal:  Clin Immunol       Date:  2002-11       Impact factor: 3.969

Review 2.  VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins.

Authors:  Alain Couvineau; Marc Laburthe
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Authors:  Anthony J Harmar; Jan Fahrenkrug; Illana Gozes; Marc Laburthe; Victor May; Joseph R Pisegna; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 4.  VIP-PACAP system in immunity: new insights for multitarget therapy.

Authors:  R P Gomariz; Y Juarranz; C Abad; A Arranz; J Leceta; C Martinez
Journal:  Ann N Y Acad Sci       Date:  2006-07       Impact factor: 5.691

5.  Expansion of unusual CD4+ T cells in severe rheumatoid arthritis.

Authors:  P B Martens; J J Goronzy; D Schaid; C M Weyand
Journal:  Arthritis Rheum       Date:  1997-06

6.  Prognostic markers of radiographic progression in early rheumatoid arthritis.

Authors:  Jörg J Goronzy; Eric L Matteson; James W Fulbright; Kenneth J Warrington; April Chang-Miller; Gene G Hunder; Thomas G Mason; Audrey M Nelson; Robert M Valente; Cynthia S Crowson; Henry A Erlich; Rebecca L Reynolds; Ronald G Swee; W Michael O'Fallon; Cornelia M Weyand
Journal:  Arthritis Rheum       Date:  2004-01

7.  Novel Senescent Regulatory T-Cell Subset with Impaired Suppressive Function in Rheumatoid Arthritis.

Authors:  Johannes Fessler; Andrea Raicht; Rusmir Husic; Anja Ficjan; Christine Schwarz; Christina Duftner; Wolfgang Schwinger; Winfried B Graninger; Martin H Stradner; Christian Dejaco
Journal:  Front Immunol       Date:  2017-03-20       Impact factor: 7.561

Review 8.  Rheumatoid Arthritis, Immunosenescence and the Hallmarks of Aging.

Authors:  Paulina Chalan; Anke van den Berg; Bart-Jan Kroesen; Liesbeth Brouwer; Annemieke Boots
Journal:  Curr Aging Sci       Date:  2015

Review 9.  The impact of senescence-associated T cells on immunosenescence and age-related disorders.

Authors:  Yuji Fukushima; Nagahiro Minato; Masakazu Hattori
Journal:  Inflamm Regen       Date:  2018-12-24

Review 10.  A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases.

Authors:  Carmen Martínez; Yasmina Juarranz; Irene Gutiérrez-Cañas; Mar Carrión; Selene Pérez-García; Raúl Villanueva-Romero; David Castro; Amalia Lamana; Mario Mellado; Isidoro González-Álvaro; Rosa P Gomariz
Journal:  Int J Mol Sci       Date:  2019-12-20       Impact factor: 5.923

View more
  2 in total

1.  Human CD4+CD45RA+ T Cells Behavior after In Vitro Activation: Modulatory Role of Vasoactive Intestinal Peptide.

Authors:  Raúl Villanueva-Romero; Alicia Cabrera-Martín; Emigdio Álvarez-Corrales; Mar Carrión; Selene Pérez-García; Amalia Lamana; David Castro-Vázquez; Carmen Martínez; Rosa P Gomariz; Irene Gutiérrez-Cañas; Yasmina Juarranz
Journal:  Int J Mol Sci       Date:  2022-02-20       Impact factor: 5.923

2.  VIP/VPAC Axis Expression in Immune-Mediated Inflammatory Disorders: Associated miRNA Signatures.

Authors:  Amalia Lamana; David Castro-Vázquez; Hortensia de la Fuente; Ana Triguero-Martínez; Rebeca Martínez-Hernández; Marcelino Revenga; Raúl Villanueva-Romero; Mar Llamas-Velasco; Pablo Chicharro; Yasmina Juarranz; Mónica Marazuela; Marco Sales-Sanz; Rosario García-Vicuña; Eva Tomero; Isidoro González-Álvaro; Carmen Martínez; Rosa P Gomariz
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.